Quality Investor
About 

Xenia Hotels & Resorts, Inc.

Rank #428Capital Return

XHR · NYSE · Real Estate

Xenia Hotels & Resorts, Inc. (XHR) — Rank #428 by gross profitability (GP/assets 0.12) · ROE 5.7% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0001616000 · all metrics point-in-time as of the filing date.

About

Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States.

Show more

The Company owns 29 hotels and resorts comprising 8,783 rooms across 14 states. Xenia's hotels are in luxury and upper-scale segments and are operated and/or licensed by industry leaders including Marriott, Hyatt, Kimpton, Fairmont, Loews, Hilton, and Davidson. Xenia Hotels & Resorts, Inc.

was incorporated in 2007 and is based in Orlando, United States.

Industry
REIT - Hotel & Motel
Sector
Real Estate
State
FL
Filer Category
Large accelerated filer
Fiscal Year End
December 31

Price History

XHR+18.2% · +3.4% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

$1.72B

P/E (annual)

27.2

P/S (annual)

1.6

P/B

1.6

P/OCF (annual)

9.8

Shareholder Yield

5.0%

Employees

42

Industry

REIT - Hotel & Motel

Exchange

NYSE

Signal Flags

2 green
Revenue growth acceleratingGrowth rate increasing year over year
Operating leverage expandingOperating income growing faster than revenue

Quality Profile

Profitability

1/1 pass
GP / assets
0.12
Return on equity
5.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.33
Current ratio
—
Net cash
-$1.25B

Cash Flow

1/1 pass
Positive FCF
N/A
Cash-backed earnings
N/A
Accruals healthy
PASS
SBC / revenue
1.2%

Growth

2/2 pass
Revenue growth
3.8%
Piotroski F-Score
N/A
Share dilution
-5.0%

Terry Smith quality gate

Passes 0/5 Terry Smith thresholds

3 of 5 thresholds not computable from filed data.

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

24.5xCheap
11.5xmed 30.0x87.1x

P / S

Price / revenue per share

1.4xCheap
1.3xmed 1.9x5.8x

P / B

Price / book value per share

1.3xExpensive
1.1xmed 1.3x1.4x

P / GP

Price / gross profit per share

4.6xCheap
4.3xmed 5.7x116.9x

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.12

Primary signal (Novy-Marx).

Return on equity

5.7%

Gross margin

30.6%

Revenue growth (YoY)

3.8%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

2.6%

Revenue CAGR (5Y)

23.9%

Earnings CAGR (3Y)

4.1%

FCF CAGR (3Y)

—

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.33

Current ratio

—

Quick ratio

—

Net cash

-$1.25B

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

—

Operating cash flow minus capex.

Positive free cash flow

N/A

FCF / net income

—

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

N/A

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.2%

Stock-based comp intensity.

Dividend safety

Composite score

1.8 / 5

Weak
Payout ratio
0.9%5/5 Strong
FCF coverage
N/A0/5 Weak
Dividend growth streak
1 yr1/5 Weak
Balance-sheet health
D/E 1.33 · IC N/A1/5 Weak

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

Lifecycle Phase History

20202025
Decline
Hypergrowth
Value
Capital Return
View full financial statements →